Safety and Effectiveness of Long-term Intravenous Administration of Edaravone for Treatment of Patients With Amyotrophic Lateral Sclerosis

Post time 2022-2-14 16:26:08

journal：JAMA Neurology

Authors：Simon Witzel; André Maier; Robert Steinbach; Julian Grosskreutz; Jan C. Koch; Anastasia Sarikidi; Susanne Petri; René Günther; Joachim Wolf; Andreas Hermann; Johannes Prudlo; Isabell Cordts; Paul Lingor; Wolfgang N. Loscher; Zacharias Kohl; Tim Hagenacker; Christian Ruckes; Birgit Koch; Susanne Spittel; Kornelia Günther; Sebastian Michels; Johannes Dorst; Thomas Meyer; Albert C. Ludolph;

Published date：--

DOI：10.1001/jamaneurol.2021.4893

Article link：http://dx.doi.org/10.1001/jamaneurol.2021.4893

Article Source：American Medical Association (AMA)。

Remark：

Post time 2022-2-14 16:26:09

: This post has been completed
Completed attachments will be deleted within 24 hours.

Post time 2022-2-14 16:41:33

: This post has been completed
Completed attachments will be deleted within 24 hours.

Post time 2022-6-19 16:20:21

: This post has been completed
Completed attachments will be deleted within 24 hours.

[JAMA] Safety and Effectiveness of Long-term Intravenous Administration of Edaravone for Treatment of Patients With Amyotrophic Lateral Sclerosis

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today